Program Overview

The North American Thrombosis Summit 2010 is a comprehensive multidisciplinary overview of major issues concerning antiplatelet agents, new anticoagulant therapies for venous and arterial thrombosis, insulin resistance on cardiovascular disease in Type II diabetes, optimal duration of VTE prophylaxis, thromboembolic pulmonary hypertension, and anticoagulant drug safety. The Summit’s objective is to improve patient care through the advancement of thrombosis education. State-of-the-art presentations will incorporate perspectives from translational science, clinical research, prevention eorts, educational initiatives, public policy, and advocacy. A panel discussion with members of NATF’s Scientic Advisory and Advocacy Committees is incorporated into the agenda. More than 30% of the curriculum is devoted to discussion, questions, and answers. The course will integrate viewpoints from academic, community, government, and patient perspectives.

Target Audience

This program is intended for patients, advocates, oce-based physicians, hospitalists, nurse practitioners, nurses, pharmacists, physician assistants, hospital administrators, and policy makers. This Activity been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Utah School of Medicine and the North American Thrombosis Forum (NATF). The University of Utah School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. AMA Credit: The University of Utah School of Medicine designates this educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: Application for nursing continuing education credit for the North American Thrombosis Summit 2010 has been submitted to the Utah Nurses Association (UNA) for consideration. UNA is an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Pharmacists: The University of Utah College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Application is pending for this program. This program is designed for all pharmacists.

Nondiscrimination and Disability Accommodation Statement: The University of Utah does not discriminate on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation and strives to provide equal access to all its programs, activities, services, and admissions. The University also complies with the Americans with Disability Act of 1990, as amended, Section 504 of the Rehabilitation Act of 1973, and other applicable federal and state laws that prohibit discrimination on the basis of disability. Reasonable accommodations will be provided to qualied individuals with disabilities upon request. Reasonable notice is required. Requests for accommodations or inquiries or complaints about these policies may be directed to the Director, OEO/AA Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax). Students may request accommodations by contacting: Director, CDS, 162 Olpin Union Bldg., Salt Lake City, UT 84112, 801-581-5020 (Voice/TTY).

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by educational grants from the following companies:

AstraZeneca
Eisai
Novo Nordisk
Ortho-McNeil	Supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc., administrated by Ortho-McNeil Janssen Scientific Affiars, LCC
sanofi aventis
Talecris Biotherapeutics